150 related articles for article (PubMed ID: 28765339)
21. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women.
Fitzpatrick AL; Daling JR; Furberg CD; Kronmal RA; Weissfeld JL
Cancer; 1997 Oct; 80(8):1438-47. PubMed ID: 9338468
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative.
Pan K; Chlebowski RT; Mortimer JE; Gunter MJ; Rohan T; Vitolins MZ; Adams-Campbell LL; Ho GYF; Cheng TD; Nelson RA
Cancer; 2020 Aug; 126(16):3638-3647. PubMed ID: 32530506
[TBL] [Abstract][Full Text] [Related]
23. C-reactive protein concentration and risk of selected obesity-related cancers in the Women's Health Initiative.
Brasky TM; Kabat GC; Ho GYF; Thomson CA; Nicholson WK; Barrington WE; Bittoni MA; Wassertheil-Smoller S; Rohan TE
Cancer Causes Control; 2018 Sep; 29(9):855-862. PubMed ID: 30046933
[TBL] [Abstract][Full Text] [Related]
24. Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women.
Wilson LE; D'Aloisio AA; Sandler DP; Taylor JA
Breast Cancer Res; 2016 Jul; 18(1):61. PubMed ID: 27378129
[TBL] [Abstract][Full Text] [Related]
25. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.
Holmes S; Griffith EJ; Musto G; Minuk GY
Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077
[TBL] [Abstract][Full Text] [Related]
26. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
[TBL] [Abstract][Full Text] [Related]
27. Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study.
Azoulay L; Soldera S; Yin H; Bouganim N
Epidemiology; 2016 Jul; 27(4):594-601. PubMed ID: 27031042
[TBL] [Abstract][Full Text] [Related]
28. Association between Post-Cancer Diagnosis Dietary Inflammatory Potential and Mortality among Invasive Breast Cancer Survivors in the Women's Health Initiative.
Zheng J; Tabung FK; Zhang J; Liese AD; Shivappa N; Ockene JK; Caan B; Kroenke CH; Hébert JR; Steck SE
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):454-463. PubMed ID: 29358225
[No Abstract] [Full Text] [Related]
29. Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study.
Sundbøll J; Schmidt M; Horváth-Puhó E; Christiansen CF; Pedersen L; Bøtker HE; Sørensen HT
BMC Neurol; 2015 Mar; 15():24. PubMed ID: 25884780
[TBL] [Abstract][Full Text] [Related]
30. Depression, Antidepressant Use, and Breast Cancer Risk in Pre- and Postmenopausal Women: A Prospective Cohort Study.
Reeves KW; Okereke OI; Qian J; Tamimi RM; Eliassen AH; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):306-314. PubMed ID: 29263188
[No Abstract] [Full Text] [Related]
31. Postdiagnostic Calcium Channel Blocker Use and Breast Cancer Mortality: A Population-based Cohort Study.
Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
Epidemiology; 2018 May; 29(3):407-413. PubMed ID: 29608546
[TBL] [Abstract][Full Text] [Related]
32. Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD).
Grimaldi-Bensouda L; Klungel O; Kurz X; de Groot MC; Maciel Afonso AS; de Bruin ML; Reynolds R; Rossignol M
BMJ Open; 2016 Jan; 6(1):e009147. PubMed ID: 26747033
[TBL] [Abstract][Full Text] [Related]
33. Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders.
Colbourne L; Harrison PJ
Mol Psychiatry; 2022 Sep; 27(9):3904-3912. PubMed ID: 35618884
[TBL] [Abstract][Full Text] [Related]
34. Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women.
Raebel MA; Zeng C; Cheetham TC; Smith DH; Feigelson HS; Carroll NM; Goddard K; Tavel HM; Boudreau DM; Shetterly S; Xu S
Am J Epidemiol; 2017 Feb; 185(4):264-273. PubMed ID: 28186527
[TBL] [Abstract][Full Text] [Related]
35. Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group.
Braun S; Boyko V; Behar S; Reicher-Reiss H; Laniado S; Kaplinsky E; Goldbourt U
J Am Coll Cardiol; 1998 Mar; 31(4):804-8. PubMed ID: 9525550
[TBL] [Abstract][Full Text] [Related]
36. Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative.
Simon MS; Beebe-Dimmer JL; Hastert TA; Manson JE; Cespedes Feliciano EM; Neuhouser ML; Ho GYF; Freudenheim JL; Strickler H; Ruterbusch J; Barac A; Chlebowski R; Caan B
Cancer; 2018 Apr; 124(8):1798-1807. PubMed ID: 29338086
[TBL] [Abstract][Full Text] [Related]
37. Use of Calcium Channel Blockers and Risk of Active Tuberculosis Disease: A Population-Based Analysis.
Lee CC; Lee MG; Hsu WT; Park JY; Porta L; Liu MA; Chen SC; Chang SC
Hypertension; 2021 Feb; 77(2):328-337. PubMed ID: 33307850
[TBL] [Abstract][Full Text] [Related]
38. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
39. Use of calcium channel blockers and myocardial infarction in hypertensive patients with rheumatoid arthritis - A nationwide cohort study.
Lin TT; Ko TY; Lin LY; Wu CK
J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):350-358. PubMed ID: 31257076
[TBL] [Abstract][Full Text] [Related]
40. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
Li CI; Chlebowski RT; Freiberg M; Johnson KC; Kuller L; Lane D; Lessin L; O'Sullivan MJ; Wactawski-Wende J; Yasmeen S; Prentice R
J Natl Cancer Inst; 2010 Sep; 102(18):1422-31. PubMed ID: 20733117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
